Iron deficiency in the elderly population, revisited in the hepcidin era

Frontiers in Pharmacology

Volumn 5 APR, Issue , 2014, Pages

  Busti, Fabiana ^a   Campostrini, Natascia ^a   Martinelli, Nicola ^a   Girelli, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Anemia; Elderly; Ferritin; Hepcidin; Iron deficiency

Indexed keywords

FERRITIN; FERROPORTIN; HEPCIDIN; IRON;

ERYTHROPOIESIS; HUMAN; IRON ABSORPTION; IRON BALANCE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON KINETICS; IRON STORAGE; IRON THERAPY; MALNUTRITION; MEAN CORPUSCULAR VOLUME; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW;

EID: 84901034908     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00083     Document Type: Review

References (93)

1. Ali, M. A., Luxton, A. V., and Walker, W. H. (1978). Serum ferritin concentration and bone marrow iron stores: a prospective study. Can. Med. Assoc. J. 118, 945-946.
2. Andrès, E., Serraj, K., Federici, L., Vogel, T., and Kaltenbach, G. (2013). Anemia in elderly patients: new insight into an old disorder. Geriatr. Gerontol. Int. 13, 519-527. doi: 10.1111/ggi.12017
3. Andrews, N. C. (2004). Anemia of inflammation: the cytokine-hepcidin link. J. Clin. Invest. 113, 1251-1253. doi: 10.1172/JCI21441
4. Auerbach, M., and Ballard, H. (2010). Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am. Soc. Hematol. Educ. Program 2010, 338-347. doi: 10.1182/asheducation-2010.1.338
5. Auerbach, M., Goodnough, L. T., and Shander, A. (2013a). Iron: the new advances in therapy. Best Pract. Res. Clin. Anaesthesiol. 27, 131-140. doi: 10.1016/j.bpa.2012.12.001
6. Auerbach, M., Strauss, W., Auerbach, S., Rineer, S., and Bahrain, H. (2013b). Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am. J. Hematol. 88, 944-947. doi: 10.1002/ajh.23534
7. Auerbach, M., Pappadakis, J. A., Bahrain, H., Auerbach, S. A., Ballard, H., and Dahl, N. V. (2011). Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am. J. Hematol. 86, 860-862. doi: 10.1002/ajh.22153
8. Batur, P., Stewart, W. J., and Isaacson, J. H. (2003). Increased prevalence of aortic stenosis in patients with arteriovenous malformations of the gastrointestinal tract in Heyde syndrome. Arch. Intern. Med. 163, 1821-1824. doi: 10.1001/archinte.163.15.1821
9. Bergamaschi, G., Di Sabatino, A., Albertini, R., Costanzo, F., Guerci, M., Masotti, M., et al. (2013). Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflamm. Bowel Dis. 19, 2166-2172. doi: 10.1097/MIB.0b013e31829a6e43
10. Beutler, E., and Waalen, J. (2006). The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107, 1747-1750. doi: 10.1182/blood-2005-07-3046
11. Blanc, B., Finch, C. A., Hallberg, L., Herbert, V., Lawkowicz, W., and Layrisse, M., et al. (1968). Nutritional anaemias report of a WHO scientific group. World Health Organ. Tech. Rep. Ser. 405, 1-40.
12. Bozzini, C., Campostrini, N., Trombini, P., Nemeth, E., Castagna, A., Tenuti, I., et al. (2008). Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol. Dis. 40, 347-352. doi: 10.1016/j.bcmd.2007.10.001
13. Bregman, D. B., Morris, D., Koch, T. A., He, A., and Goodnough L. T. (2013). Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia. Am. J. Hematol. 88, 97-101. doi: 10.1002/ajh.23354
14. Campostrini, N., Traglia, M., Martinelli, N., Corbella, M., Cocca, M., Manna, D., et al. (2012). Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study. J. Proteomics 76 Spec No.:28-35. doi: 10.1016/j.jprot.2012.08.006
15. Carmel, R. (2008). Nutritional anemias and the elderly. Semin. Hematol. 45, 225-234. doi: 10.1053/j.seminhematol.2008.07.009
16. Casale, G., Bonora, C., Migliavacca, A., Zurita, I. E., and de Nicola, P. (1981). Serum ferritin and ageing. Age Ageing 10, 119-122. doi: 10.1093/ageing/10.2.119
17. Castagna, A., Campostrini, N., Zaninotto, F., and Girelli, D. (2010). Hepcidin assay in serum by SELDI-TOF-MS and other approaches. J. Proteomics 73, 527-536. doi: 10.1016/j.jprot.2009.08.003
18. Chaves, P. H., Xue, Q. L., Guralnik, J. M., Ferrucci, L., Volpato, S., and Fried, L. P. (2004). What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J. Am. Geriatr. Soc. 2, 1811-1816. doi: 10.1111/j.1532-5415.2004.52502.x
19. Clark, S. F. (2008). Iron deficiency anemia. Nutr. Clin. Prat. 23, 128-141. doi: 10.1177/0884533608314536
20. Clark, S. F. (2009). Iron deficiency anemia: diagnosis and management. Curr. Opin. Gastroenterol. 25, 122-128. doi: 10.1097/MOG.0b013e32831ef1cd
21. Cook, J. D. (2005). Diagnosis and management of iron-deficiency anaemia. Best Pract. Clin. Res. 18, 319-332. doi: 10.1016/j.beha.2004.08.022
22. Culleton, B. F., Manns, B. J., Zhang, J., Tonelli, M., Klarenbach, S., and Hemmelgarn, B. R. (2006). Impact of anemia on hospitalization and mortality in older adults. Blood 107, 3841-3846. doi: 10.1182/blood-2005-10-4308
23. Darshan, D., Frazer, D. M., Wilkins, S. J., and Anderson, G. J. (2010). Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide. Haematologica 95, 1660-1667. doi: 10.3324/haematol.2010.022426
24. De Domenico, I., Ward, D. M., and Kaplan, J. (2011). Hepcidin and ferroportin: the new players in iron metabolism. Semin. Liver Dis. 31, 272-279. doi: 10.1055/s-0031-1286058
25. den Elzen, W. P., de Craen, A. J., Wiegerinck, E. T., Westendorp, R. G., Swinkels, D. W., and Gussekloo, J. (2013). Plasma hepcidin levels and anemia in old age. The leiden 85-plus study. Haematologica 98, 448-454. doi: 10.3324/haematol.2012.068825
26. den Elzen, W. P., Willems J. M., Westendorp, R. G. J., de Craen, A. J., Assendeft, W. J., and Gussekloo J. (2009). Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ 181, 151-157. doi: 10.1503/cmaj.090040
27. Denny, S. D., Kuchibhatla, M. N., and Cohen, H. J. (2006). Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am. J. Med. 119, 327-334. doi: 10.1016/j.amjmed.2005.08.027
28. Eddy, D. M. (1990). Screening for colorectal cancer. Ann. Intern. Med. 113, 373-384. doi: 10.7326/0003-4819-113-5-373
29. Eisenstaedt, R., Pennix, B. W., and Woodman, R. C. (2006). Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 20, 213-226. doi: 10.1016/j.blre.2005.12.002
30. Evstatiev, R., Marteau, P., Iqbal, T., Khalif, I. L., Stein, J., Bokemeyer, B., et al. (2011). FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 141, 846-853. doi: 10.1053/j.gastro.2011.06.005
31. Fairweather-Tait, S., Wawer, A., Gillings, R., Jennings, A., and Myint, P. K. (2013). Iron status in the elderly. Mech. Ageing Dev. doi: 10.1016/j.mad.2013.11.005 [Epub ahead of print].
32. Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., et al. (2005). The origins of age-related proinflammatory state. Blood 105, 2294-2299. doi: 10.1182/blood-2004-07-2599
33. Ferrucci, L., Semba, R. D., Guralnik, J. M., Ershler, W. B., Bandinelli, S., Patel, K. V., et al. (2010). Proinflammatory state, hepcidin, and anemia in older persons. Blood 115, 3810-3816. doi: 10.1182/blood-2009-02-201087
34. Fishbane, S. (2003). Safety in iron management. Am. J. Kidney Dis. 41, 18-26. doi: 10.1016/S0272-6386(03)00373-1
35. Freeman, H. J. (2008). Adult celiac disease in the elderly. World J. Gastroenterol. 14, 6911-6914. doi: 10.3748/wjg.14.6911
36. Galesloot, T. E., Vermeulen, S. H., Geurts-Moespot, A. J., Klaver, S. M., Kroot, J. J., van Tienoven, D., et al. (2011). Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 117, e218-e225. doi: 10.1182/blood-2011-02-337907
37. Ganz, T. (2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102, 783-788. doi: 10.1182/blood-2003-03-0672
38. Ganz, T. (2013). Systemic iron homeostasis. Physiol. Rev. 93, 1721-1741. doi: 10.1152/physrev.00008
39. Ganz T., and Nemeth E. (2011). Hepcidin and disorders of iron metabolism. Annu. Rev. Med. 62, 347-360. doi: 10.1146/annurev-med-050109-142444
40. Ganz, T., Olbina, G., Girelli, D., Nemeth, E., and Westerman, M. (2008). Immunoassay for human serum hepcidin. Blood 112, 4292-4297. doi: 10.1182/blood-2008-02-139915
41. Gardenghi, S., Renaud, T. M., Meloni, A., Casu, C., Crielaard, B. J., Bystrom, L. M., et al. (2014). Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 123, 1137-1145. doi: 10.1182/blood-2013-08-521625
42. Goddard, A. F., James, M. W., McIntyre, A. S., Scott, B. B., and British Society of Gastroenterology. (2011). Guidelines for the management of iron deficiency anemia. Gut 60, 1309-1316. doi: 10.1136/gut.2010.228874
43. Goodnough, L. T. (2012). Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion 52, 1584-1592. doi: 10.1111/j.1537-2995.2011.03495.x
44. Goodnough, L. T., Nemeth, E., and Ganz, T. (2010). Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116, 4754-4761. doi: 10.1182/blood-2010-05-286260
45. Goodnough, L. T., and Schrier, S. L. (2014). Evaluation and management of anemia in the elderly. Am. J. Hematol. 89, 88-96. doi: 10.1002/ajh.23598
46. Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., and Woodman, R. C. (2004). Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104, 2263-2268. doi: 10.1182/blood-2004-05-1812
47. Guyatt, G. H., Patterson, C., Ali, M., Singer, J., Levine, M., Turpie, I., et al. (1990). Diagnosis of iron-deficiency anemia in the elderly. Am. J. Med. 88, 205-209. doi: 10.1016/0002-9343(90)90143-2
48. Harper, J. W., Holleran, S. F., Ramakrishnan, R., Bhagat, G., and Green, P. H. (2007). Anemia in celiac disease is multifactorial in etiology. Am. J. Hematol. 82, 996-1000. doi: 10.1002/ajh.20996
49. Hershko, C., and Camaschella, C. (2013). How I treat unexplained refractory iron deficiency anemia. Blood 123, 326-333. doi: 10.1182/blood-2013-10-512624
50. Izaks, G. J., Westendorp, R. G., and Knook, D. L. (1999). The definition of anemia in older person. JAMA 281, 1714-1717. doi: 10.1001/jama.281.18.1714
51. Joosten, E., Hiele, M., Ghoos, Y., Pelemans, W., and Boogaerts M. A. (1991). Diagnosis of iron-deficiency anemia in a hospitalized geriatric population. Am. J. Med. 90, 653-654.
52. Kautz, L., Nemeth, E., and Ganz, T. (2013). The erythroid factor erythroferrone and its role in iron homeostasis. Am. J. Hematol. 88, E24.
53. Kim, A., Fung, E., Parikh, S. G., Valore, E. V., Gabayan, V., Nemeth, E., et al. (2014). A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 123, 1129-1136. doi: 10.1182/blood-2013-08-521419
54. Kroot, J. J., Tjalsma, H., Fleming, R. E., and Swinkels, D. W. (2011). Hepcidin in human iron disorders: diagnostic implications. Clin. Chem. 57, 1650-1669. doi: 10.1373/clinchem.2009.140053
55. Lipschitz, D. A., Cook, J. D., and Finch, C. A. (1974). A clinical evaluation of serum ferritin as an index of iron stores. N. Engl. J. Med. 290, 1213-1216. doi: 10.1056/NEJM197405302902201
56. Loscalzo J. (2012). From clinical observation to mechanisms. Heyde's syndrome. N. Engl. J. Med. 367, 1954-1956. doi: 10.1056/NEJMcibr1205363
57. McCranor, B. J., Langdon, J. M., Prince, O. D., Femnou, L. K., Berger, A. E., Cheadle, C., et al. (2013). Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age. Haematologica 98, 1633-1640. doi: 10.3324/haematol.2013.087114
58. Maggio, M., Guralnik, J. M., Longo, D. L., and Ferrucci, L. (2006). Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci. 61, 575-584. doi: 10.1093/gerona/61.6.575
59. Makipour, S., Kanapuru, B., and Ershler, W. B. (2008). Unexplained anemia in the elderly. Semin. Hematol. 45, 250-254. doi: 10.1053/j.seminhematol.2008.06.003
60. Mast, A. E, Blinder, M. A., Gronowski, A. M., Chumley, C., and Scott, M. G. (1998). Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin. Chem. 44, 45-51.
61. Meynard, D., Babitt, J. L., and Lin, H. Y. (2014). The liver, conductor of systemic iron balance. Blood 123, 168-176. doi: 10.1182/blood-2013-06-427757
62. Mindell, J., Moody, A., Ali, A., and Hirani, V. (2013). Using longitudinal data from the Health Survey for England to resolve discrepancies in thresholds for haemoglobin in older adults. Br. J. Haematol. 160, 368-376. doi: 10.1111/bjh.12121
63. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., et al. (2004). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276. doi: 10.1172/JCI200420945
64. Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., and Ganz, T. (2003). Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461-2463. doi: 10.1182/blood-2002-10-3235
65. Onken, J. E., Bregman, D. B., Harrington, R. A., Morris, D., Acs, P., Akright, B., et al. (2014). A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion 54, 306-315. doi: 10.1111/trf.12289
66. Pasricha, S. R., Flecknoe-Brown, S. C., Allen, K. J., Gibson, P. R., McMahon, L. P., Olynyk, J. K., et al. (2010). Diagnosis and management of iron deficiency anaemia: a clinical update. Med. J. Aust. 193, 525-532.
67. Pasricha, S. R., McQuilten, Z., Westerman, W., Keller, A., Nemeth, W., Ganz, T., et al. (2011). Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica 96, 1099-1105. doi: 10.3324/haematol.2010.037960
68. Patel, D., Kalkat, P., Baisch, D., and Zipser, R. (2005). Celiac disease in the elderly. Gerontology 51, 213-214. doi: 10.1159/000083996
69. Patel, K. V. (2008). Epidemiology of anemia in older adults. Semin. Hematol. 45, 210-217. doi: 10.1053/j.seminhematol.2008.06.006
70. Penninx, B. W., Pahor, M., Woodman, R. C., and Guralnik, J. M. (2006). Anemia in old age is associated with increased mortality and hospitalization. J. Gerontol. A Biol. Sci. Med. Sci. 61, 474-479. doi: 10.1093/gerona/61.5.474
71. Petrosyan, I., Blaison, G., Andrès, E., and Federici, L. (2012). Anemia in the elderly: etiologic profile in a prospective cohort of 95 hospitalized patients. Eur. J. Intern. Med. 23, 524-528. doi: 10.1016/j.ejim.2012.03.013
72. Pfeiffer, C. M., Cook, J. D., Mei, Z., Cogswell, M. E., Looker, A. C., and Lacher, D. A. (2007). Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin. Chim. Acta 382, 112-116. doi: 10.1016/j.cca.2007.04.008
73. Pounder, R. E., and Ng, D. (1995). The prevalence of Helicobacter pylori infection in different countries. Aliment. Pharmacol. Ther. 9, 33-39.
74. Price, E. A., Mehra, R., Holmes, T. H., and Schrier, S. L. (2011). Anemia in older persons: etiology and evaluation. Blood Cells Mol. Dis. 46, 159-165. doi: 10.1016/j.bcmd.2010.11.004
75. Punnonen, K., Irjala, K., and Rajamaki, A. (1997). Serum ferritin and its ratio to serum ferritin in the diagnosis iron deficiency. Blood 89, 1052-1057.
76. Rashtak, S., and Murray, J. A. (2009). Celiac disease in the elderly. Gastroenterol. Clin. North. Am. 38, 433-446. doi: 10.1016/j.gtc.2009.06.005
77. Reimer, C. (2013). Safety of long-term PPI therapy. Best Pract. Res. Clin. Gastroenterol. 27, 443-454. doi: 10.1016/j.bpg.2013.06.001.
78. Richter, J. M., Hedberg, S. E., Athanasoulis, C. A., and Schapiro, R. H. (1984). Angiodysplasia. Clinical presentation and colonoscopic diagnosis. Dig. Dis. Sci. 29, 481-485. doi: 10.1007/BF01296266
79. Rimon, E., Levy, S., Sapir, A., Gelzer, G., Peled, R., Ergas, D., et al. (2002). Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch. Intern. Med. 162, 445-449. doi: 10.1001/archinte.162.4.445
80. Sami, S. S., Al-Araji, S. A., and Ragunath, K. (2014). Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management. Aliment. Pharmacol. Ther. 39, 15-34. doi: 10.1111/apt.12527
81. Silverstein, S. B., and Rodgers, G. M. (2004). Parenteral iron therapy options. Am. J. Hematol. 76, 74-78. doi: 10.1002/ajh.20056
82. Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., et al. (2009). Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113, 5277-5286. doi: 10.1182/blood-2008-12-195651
83. Traglia, M., Girelli, D., Biino, G., Campostrini, N., Corbella, M., Sala, C., et al. (2011). Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. J. Med. Genet. 48, 629-634. doi: 10.1136/jmedgenet-2011-100061
84. Vanasse, G. J., and Berliner, N. (2010). Anemia in elderly patients: an emerging problem for the 21st century. Hematology Am. Soc. Hematol. Educ. Program 2010, 271-275. doi: 10.1182/asheducation-2010.1.271
85. van Santen, S., van Dongen-Lases, E. C., de Vegt, F., Laarakkers, C. M., van Riel, P. L., van Ede, A. E., et al. (2011). Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 63, 3672-3680. doi: 10.1002/art.30623
86. Vilppula, A., Kaukinen, K., Luostarinen, L., Krekelä, I., Patrikainen, H., Valve, R., et al. (2009). Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol. 9:49. doi: 10.1186/1471-230X-9-49
87. Vincentelli, A., Susen, S., Le Tourneau, T., Six, I., Fabre, O., Juthier, F., et al. (2003). Acquired von Willebrand syndrome in aortic stenosis. N. Engl. J. Med. 349, 343-349. doi: 10.1056/NEJMoa022831
88. Waalen, J., von Lohnneysen, K., Lee, P., Xu, X., and Friedman, J. S. (2011). Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur. J. Haematol. 87, 107-116. doi: 10.1111/j.1600-0609.2011.01631.x
89. Weiss, G., and Goodnough, L. T. (2005). Anemia of chronic disease. N. Engl. J. Med. 352, 1011-1023. doi: 10.1056/NEJMra041809
90. Wikstrom, B., Bhandari, S., Barany, P., Kalra, P. A., Ladefoged, S., Wilske, J. J., et al. (2011). Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. J. Nephrol. 24, 589-596. doi: 10.5301/JN.2011.6248
91. Woodman, R., Ferrucci, L., and Guralnik, J. (2005). Anemia in older adults. Curr. Opin. Hematol. 12, 123-128.
92. World Health Organization (WHO). (2001). Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Program Managers. Geneva: World Health Organization (WHO/NHD/01.3).
93. Zakai, N. A., Katz, R., Hirsch, C., Shlipak, M. G., Chaves, P. H., Newman, A. B., et al. (2005). A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch. Intern. Med. 165, 2214-2220. doi: 10.1001/archinte.165.19.2214